These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 29520760)

  • 61. Graphene oxide polarizes iNKT cells for production of TGFβ and attenuates inflammation in an iNKT cell-mediated sepsis model.
    Lee SW; Park HJ; Van Kaer L; Hong S; Hong S
    Sci Rep; 2018 Jul; 8(1):10081. PubMed ID: 29973666
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Characterization of the immature dendritic cells and cytotoxic cells both expanded after activation of invariant NKT cells with alpha-galactosylceramide in vivo.
    Tamura Y; Teng A; Nozawa R; Takamoto-Matsui Y; Ishii Y
    Biochem Biophys Res Commun; 2008 May; 369(2):485-92. PubMed ID: 18284915
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Antigen mRNA-transfected, allogeneic fibroblasts loaded with NKT-cell ligand confer antitumor immunity.
    Fujii S; Goto A; Shimizu K
    Blood; 2009 Apr; 113(18):4262-72. PubMed ID: 19164596
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Distribution of invariant natural killer T cells and dendritic cells in late pre-term birth without acute chorioamnionitis.
    Negishi Y; Shima Y; Takeshita T; Takahashi H
    Am J Reprod Immunol; 2017 Jun; 77(6):. PubMed ID: 28276165
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Novel thioglycoside analogs of α-galactosylceramide stimulate cytotoxicity and preferential Th1 cytokine production by human invariant natural killer T cells.
    Melo AM; Zhang L; Dockry ÉF; Petrasca A; Ghnewa YG; Breen EP; Morrissey ME; O'Reilly C; Bruen R; O'Meara A; Lysaght J; Zhu X; Doherty DG
    Glycobiology; 2018 Jul; 28(7):512-521. PubMed ID: 29688330
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Activation of invariant NKT cells exacerbates experimental visceral leishmaniasis.
    Stanley AC; Zhou Y; Amante FH; Randall LM; Haque A; Pellicci DG; Hill GR; Smyth MJ; Godfrey DI; Engwerda CR
    PLoS Pathog; 2008 Feb; 4(2):e1000028. PubMed ID: 18463695
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Invariant NKT cells act as an adjuvant to enhance Th2 inflammatory response in an OVA-induced mouse model of asthma.
    Nie H; Yang Q; Zhang G; Wang A; He Q; Liu M; Li P; Yang J; Huang Y; Ding X; Yu H; Hu S
    PLoS One; 2015; 10(4):e0119901. PubMed ID: 25830340
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Altered invariant natural killer T cell subsets and its functions in patients with oral squamous cell carcinoma.
    Singh AK; Shukla NK; Das SN
    Scand J Immunol; 2013 Nov; 78(5):468-77. PubMed ID: 23980793
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Co-operation of α-galactosylceramide-loaded tumour cells and TLR9 agonists induce potent anti-tumour responses in a murine colon cancer model.
    Dong T; Yi T; Yang M; Lin S; Li W; Xu X; Hu J; Jia L; Hong X; Niu W
    Biochem J; 2016 Jan; 473(1):7-19. PubMed ID: 26450924
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Modulation of acute graft-versus-host disease and chimerism after adoptive transfer of in vitro-expanded invariant Valpha14 natural killer T cells.
    Kuwatani M; Ikarashi Y; Iizuka A; Kawakami C; Quinn G; Heike Y; Yoshida M; Asaka M; Takaue Y; Wakasugi H
    Immunol Lett; 2006 Jul; 106(1):82-90. PubMed ID: 16806496
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Solubilization of α-galactosylceramide in aqueous medium: Impact on Natural Killer T cell activation and antitumor responses.
    Macho-Fernandez E; Chekkat N; Ehret C; Thomann JS; De Giorgi M; Spanedda MV; Bourel-Bonnet L; Betbeder D; Heurtault B; Faveeuw C; Fournel S; Frisch B; Trottein F
    Int J Pharm; 2017 Sep; 530(1-2):354-363. PubMed ID: 28743554
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Migration, Distribution, and Safety Evaluation of Specific Phenotypic and Functional Mouse Spleen-Derived Invariant Natural Killer T2 Cells after Adoptive Infusion.
    Chen D; Xu W; Teng J; Liu H; Wang Y; Wang Y; Cheng S; Meng M
    Mediators Inflamm; 2021; 2021():5170123. PubMed ID: 34924812
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Significance of Frequencies, Compositions, and/or Antileukemic Activity of (DC-stimulated) Invariant NKT, NK and CIK Cells on the Outcome of Patients With AML, ALL and CLL.
    Boeck CL; Amberger DC; Doraneh-Gard F; Sutanto W; Guenther T; Schmohl J; Schuster F; Salih H; Babor F; Borkhardt A; Schmetzer H
    J Immunother; 2017; 40(6):224-248. PubMed ID: 28557814
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Imaging α-GalCer-Activated iNKT Cells in a Hepatic Metastatic Environment.
    Babes L; Shim R; Kubes P
    Cancer Immunol Res; 2022 Jan; 10(1):12-25. PubMed ID: 34785505
    [TBL] [Abstract][Full Text] [Related]  

  • 75. CXCL16-positive dendritic cells enhance invariant natural killer T cell-dependent IFNγ production and tumor control.
    Veinotte L; Gebremeskel S; Johnston B
    Oncoimmunology; 2016 Jun; 5(6):e1160979. PubMed ID: 27471636
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Exogenous Activation of Invariant Natural Killer T Cells by α-Galactosylceramide Reduces Pneumococcal Outgrowth and Dissemination Postinfluenza.
    Barthelemy A; Ivanov S; Hassane M; Fontaine J; Heurtault B; Frisch B; Faveeuw C; Paget C; Trottein F
    mBio; 2016 Nov; 7(6):. PubMed ID: 27803187
    [TBL] [Abstract][Full Text] [Related]  

  • 77. PD-L1 and PD-L2 modulate airway inflammation and iNKT-cell-dependent airway hyperreactivity in opposing directions.
    Akbari O; Stock P; Singh AK; Lombardi V; Lee WL; Freeman GJ; Sharpe AH; Umetsu DT; Dekruyff RH
    Mucosal Immunol; 2010 Jan; 3(1):81-91. PubMed ID: 19741598
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Targeted Co-delivery of Tumor Antigen and α-Galactosylceramide to CD141
    Huang J; Zhou J; Ghinnagow R; Seki T; Iketani S; Soulard D; Paczkowski P; Tsuji Y; MacKay S; Cruz LJ; Trottein F; Tsuji M
    Front Immunol; 2020; 11():2043. PubMed ID: 32973811
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Invariant NKT Cell Activation Induces Late Preterm Birth That Is Attenuated by Rosiglitazone.
    St Louis D; Romero R; Plazyo O; Arenas-Hernandez M; Panaitescu B; Xu Y; Milovic T; Xu Z; Bhatti G; Mi QS; Drewlo S; Tarca AL; Hassan SS; Gomez-Lopez N
    J Immunol; 2016 Feb; 196(3):1044-59. PubMed ID: 26740111
    [TBL] [Abstract][Full Text] [Related]  

  • 80. CD1d-mediated stimulation of natural killer T cells selectively activates hepatic natural killer cells to eliminate experimentally disseminated hepatoma cells in murine liver.
    Miyagi T; Takehara T; Tatsumi T; Kanto T; Suzuki T; Jinushi M; Sugimoto Y; Sasaki Y; Hori M; Hayashi N
    Int J Cancer; 2003 Aug; 106(1):81-9. PubMed ID: 12794761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.